Conference Coverage
Conference Coverage
IV secukinumab, alternative to self-injections, reaches primary endpoints in PsA, axSpA
Two phase 3 trials of the recently approved IV formulation of secukinumab showed its efficacy versus placebo in treating psoriatic arthritis and...
Conference Coverage
Sepsis mortality greater in Black than White children despite similar interventions
The findings reveal how structural racism and inequalities built into the U.S. health care system put Black children and other communities at...
Conference Coverage
Low-dose aspirin reduces liver fat, inflammation markers
“I’m encouraged by the results with low-dose aspirin, and I think that, given the risk profile, using a lower dose is preferable.”
Latest News
Albuminuria reduction fuels finerenone’s kidney benefits
Mediation analyses of finerenone trial data show most of the drug’s kidney benefit and a third of its CVD benefit comes from cutting albuminuria...
Latest News
‘Love more’: Why doctors should promote social connection
Embracing community and close relationships helps people live longer and be happier.
Latest News
First referral guide issued for axial spondyloarthritis
The draft recommendations are a “good first step,” but more awareness around axial spondyloarthritis in the nonrheumatology community is also...
Conference Coverage
Pharmacist-based strategy places more patients on statins
In two studies run in parallel fashion, testing different strategies, automatic referral to a pharmacist was superior to EHR alerts for increasing...
Conference Coverage
Low-salt diet cut BP by 6 mm Hg in 1 week: CARDIA-SSBP
“The blood pressure reduction we see here is ... comparable to that produced by one antihypertensive medication,” said Dr. Deepak Gupta.
Conference Coverage
Study takes fine-grained look at MACE risk with glucocorticoids in RA
The level of risk for MACE rose with the dose, duration, and recency of GC use, and risk increased significantly at prednisone-equivalent doses as...
Conference Coverage
Saltwater gargling may help avoid COVID hospitalization
Hospitalization rates in the low- (18.5%) and high- (21.4%) saline groups were significantly lower than in the reference control population.
Conference Coverage
Weight-loss drugs improve liver measures, too
Body weight reduction of at least 3% within 8 weeks of beginning treatment with either an SLT-2 or GLP-1 agent was associated independently with...